Lee Ainslie - Maverick Capital
Holding/activity history for Collegium Pharmaceutical Inc. (COLL)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q3 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2023 Q2 | 10,401 | 0.00 | Reduce 7.92% | 0.00 | $21.54 |
| 2023 Q1 | 11,296 | 0.01 | Add 5.17% | 0.00 | $23.99 |
| 2022 Q4 | 10,741 | 0.01 | Reduce 27.09% | 0.00 | $23.18 |
| 2022 Q3 | 14,732 | 0.01 | Buy | 0.01 | $16.02 |
| 2021 Q3 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2021 Q2 | 33,751 | 0.01 | Buy | 0.01 | $23.64 |
| 2021 Q1 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2020 Q4 | 6,926 | 0.00 | Buy | 0.00 | $20.07 |
| 2019 Q2 | 0 | 0 | Sell 100.00% | 0.08 | |
| 2019 Q1 | 395,080 | 0.08 | Buy | 0.08 | $15.14 |
| 2018 Q4 | 0 | 0 | Sell 100.00% | 0.08 | |
| 2018 Q3 | 421,993 | 0.08 | Reduce 0.61% | 0.00 | $14.74 |
| 2018 Q2 | 424,590 | 0.12 | Buy | 0.12 | $23.85 |